Sopheon PLC
02 December 2003
Embargoed Release: 07:00hrs 2nd December 2003
Sopheon Plc
('Sopheon')
Sopheon Product Development System Adopted by Revlon
MINNEAPOLIS and LONDON 3/4 Dec. 2nd, 2003 3/4 Sopheon, the international
software and services company, announced today that Revlon Consumer Products
Corporation, a globally known mass-market leader in cosmetics, skin care,
fragrances and personal care products, has entered into an agreement with
Sopheon pursuant to which Revlon has licensed Sopheon's Accolade product
development system.
'There are many benefits associated with Accolade's growing market momentum,'
said Andy Michuda, chief executive officer of Sopheon. 'One of the greatest is
the fact that it creates opportunities for us to work with global industry
leaders such as Revlon. Increasingly, we are also teaming with leading advisory
firms such as Deloitte Consulting, experts at helping companies build product
strategies that can drive sustained organic growth and a partner in the Revlon
implementation. Of course, the real winner in this kind of collaboration is the
client. We believe that the product development system Revlon has put in place
is among the best in the industry.'
Sopheon's Accolade is the industry's first product development system that
integrates human- based decision-support services and process-enabling
technology for the comprehensive management of product and technology
portfolios. In addition to automating the product development process, Accolade
offers such features as an idea management and screening module that captures,
tracks and enables objective evaluation of product ideas; portfolio management
tools that allow the early identification of the most commercially promising
product development concepts; and a knowledge network that facilitates the
transfer of information and know-how across value chains to improve the speed
and effectiveness of decision making.
About Revlon
Revlon (NYSE: REV) is a worldwide cosmetics, skin care, fragrance, and personal
care products company. The Company's vision is to become the world's most
dynamic leader in global beauty and skin care. Websites featuring current
product and promotional information, as well as corporate investor relations
information, can be reached at www.revlon.com, www.almay.com and
www.revloninc.com. The Company's brands, which are sold worldwide, include
Revlon(R), Almay(R), Ultima II(R), Charlie (R), Flex (R), and Mitchum(R).
About Sopheon
Sopheon (LSE: SPE) is an international provider of software and services that
help organizations improve the business impact of product development. The
Sopheon Accolade(R) product development system automates gate-or phase-based
product development processes and provides strategic decision support that
allows companies to improve innovation, cut product development spending waste
and shorten time to market. Sopheon's Monitor software operates as a 'reading
robot' that automatically reviews, filters, analyzes and pushes relevant content
to healthcare and engineering professionals to enable effective compliance with
protocols, standards and regulations. Sopheon is listed on the AIM Market of the
London Stock Exchange and on the Euronext in the Netherlands. For more
information, please visit www.sopheon.com.
Further Information:
Barry Mence, Chairman Sopheon plc Tel: + 44 (0) 1483 685 735
Arif Karimjee, CFO
Adam Reynolds Hansard Communications Tel: + 44 (0) 207 245 1100
Andrew Tan + 44 (0) 7957 203 685
Barbara Jansen Citigate First Financial Tel: + 31 (0) 205 754 010
This information is provided by RNS
The company news service from the London Stock Exchange
*A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:
Obtains access to the information in a personal capacity;
Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
Please note, this site uses cookies. Some of the cookies are essential for parts of the site to operate and have already been set. You may delete and block all cookies from this site, but if you do, parts of the site may not work. To find out more about the cookies used on Investegate and how you can manage them, see our Privacy and Cookie Policy
To continue using Investegate, please confirm that you are a private investor as well as agreeing to our Privacy and Cookie Policy & Terms.